Related Experiment Videos
Genetic evaluation for coronary artery disease.
1Cedars-Sinai Medical Center, Associate Professor of Medicine, David Geffen School of Medicine, UCLA, CDC Office of Genomics and Disease Prevention, Los Angeles, California, USA.
Summary
Family history is key to identifying genetic risk for coronary artery disease (CAD). Stratifying familial risk can enhance CAD prevention strategies and guide targeted interventions for affected individuals.
Area of Science:
- Cardiovascular Genetics
- Preventive Cardiology
- Medical Genetics
Background:
- Genetic factors significantly contribute to coronary artery disease (CAD) development.
- Family history assessment is the primary method for identifying individuals with genetic susceptibility to CAD.
- Family history integrates genetic, environmental, cultural, and behavioral influences on CAD risk.
Purpose of the Study:
- To explore the utility of familial risk stratification in improving CAD risk assessment.
- To identify strategies for enhanced CAD prevention based on familial risk.
- To determine the role of genetic evaluation in high-risk individuals.
Main Methods:
- Stratification of familial risk based on number of affected relatives, age of onset, associated conditions, and gender.
- Integration of familial risk stratification with existing CAD risk assessment tools (e.g., Framingham score, ATP III guidelines).
- Consideration of genetic evaluation, including pedigree analysis, genetic counseling, and DNA-based testing for high-risk individuals.
Main Results:
- Familial risk stratification allows categorization into average, moderate, or high-risk groups.
- Targeted risk factor modification is recommended for individuals with increased familial risk.
- Early detection, biochemical, and DNA-based testing can refine risk assessment in high-risk populations.
Conclusions:
- Familial risk stratification offers a valuable approach to enhance standard CAD risk assessment and treatment.
- Individuals with the highest familial risk may benefit from genetic evaluation for potential mendelian disorders.
- Further research is needed to evaluate the clinical utility and ethical implications of integrating familial risk stratification and genetic evaluation into CAD prevention.